MICB and neoplasm: Treatment of colon carcinoma cells with entinostat led to enhancement of acetylated histone 3 (AcH3) binding to MICA and MICB promoters, increasing their expression in a dose and time-dependent manner, resulting in higher NK cell-mediated tumor cell lysis, as compared to untreated cells.